My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (Text with EEA relevance)

Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (Text with EEA relevance)

Implementing Regulation (EU) 2016/950 Β· Regulation Β· 3 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

Open β†—

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open β†—

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open β†—

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 29, Ethofumesate, the date is replaced by β€˜31 July 2017’; (2) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by β€˜31 October 2017’; (3) in the sixth column, expiration of approval, of row 41, Imazamox, the date is replaced by β€˜31 July 2017’; (4) in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by β€˜31 July 2017’; (5) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by β€˜31 July 2017’; (6) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by β€˜31 July 2017’; (7) in the sixth column, expiration of approval, of row 47, 2,4-DB, the date is replaced by β€˜31 October 2017’; (8) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by β€˜31 October 2017’; (9) in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by β€˜31 October 2017’; (10) in the sixth column, expiration of approval, of row 51, Linuron, the date is replaced by β€˜31 July 2017’; (11) in the sixth column, expiration of approval, of row 52, Maleic hydrazide, the date is replaced by β€˜31 October 2017’; (12) in the sixth column, expiration of approval, of row 53, Pendimethalin, the date is replaced by β€˜31 July 2017’; (13) in the sixth column, expiration of approval, of row 59, Trifloxystrobin, the date is replaced by β€˜31 July 2017’; (14) in the sixth column, expiration of approval, of row 60, Carfentrazone ethyl, the date is replaced by β€˜31 July 2017’; (15) in the sixth column, expiration of approval, of row 61, Mesotrione, the date is replaced by β€˜31 July 2017’; (16) in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by β€˜31 July 2017’; (17) in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by β€˜31 July 2017’; (18) in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by β€˜31 October 2017’; (19) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by β€˜31 October 2017’; (20) in the sixth column, expiration of approval, of row 66, Iodosulfuron, the date is replaced by β€˜31 October 2017’; (21) in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by β€˜31 October 2017’; (22) in the sixth column, expiration of approval, of row 68, Picoxystrobin, the date is replaced by β€˜31 October 2017’; (23) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by β€˜31 October 2017’; (24) in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by β€˜31 October 2017’; (25) in the sixth column, expiration of approval, of row 71, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), the date is replaced by β€˜31 October 2017’.

Other acts of the same type
Regulation (EU) 2018/1862 of the European Parliament and of the Council of 28 November 2018 on the establishment, operation and use of the Schengen Information System (SIS) in the field of police cooperation and judicial cooperation in criminal matters, amending and repealing Council Decision 2007/533/JHA, and repealing Regulation (EC) No 1986/2006 of the European Parliament and of the Council and Commission Decision 2010/261/EUCouncil Implementing Regulation (EU) 2018/1863 of 28 November 2018 implementing Article 21(1) of Regulation (EU) 2016/44 concerning restrictive measures in view of the situation in LibyaCommission Implementing Regulation (EU) 2018/1864 of 28 November 2018 concerning the classification of certain goods in the Combined NomenclatureCommission Implementing Regulation (EU) 2018/1865 of 28 November 2018 concerning the non-renewal of approval of the active substance propiconazole, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1866 of 28 November 2018 amending Regulation (EC) No 474/2006 as regards the list of air carriers which are banned from operating or are subject to operational restrictions within the Union (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1873 of 28 November 2018 amending Regulation (EC) No 1484/95 as regards fixing representative prices in the poultrymeat and egg sectors and for egg albuminCommission Delegated Regulation (EU) 2019/227 of 28 November 2018 amending Delegated Regulation (EU) No 1062/2014 as regards certain active substances/product-type combinations for which the competent authority of the United Kingdom has been designated as the evaluating competent authority (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1853 of 27 November 2018 granting a Union authorisation for the biocidal product family Teat disinfectants biocidal product family of CVAS (Text with EEA relevance.)Commission Regulation (EU) 2018/1847 of 26 November 2018 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1848 of 26 November 2018 on the reimbursement, in accordance with Article 26(5) of Regulation (EU) No 1306/2013 of the European Parliament and of the Council, of the appropriations carried over from financial year 2018Commission Implementing Regulation (EU) 2018/1852 of 26 November 2018 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications [β€˜MahΓ³n-Menorca’ (PDO)]Council Regulation (EU) 2018/1877 of 26 November 2018 on the financial regulation applicable to the 11th European Development Fund, and repealing Regulation (EU) 2015/323

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next